Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ph+ ALL in Chinese Children: Diagnosis, Treatment, and Survival
Sponsor: The Children's Hospital of Zhejiang University School of Medicine
Summary
The study aims to conduct a real-world investigation of children with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in China, assessing their diagnosis, treatment status, survival outcomes, and prognostic factors. The research will involve children diagnosed with Ph+ ALL between January 1, 2015, and December 31, 2024. Our objective is to understand the incidence and prognosis of CML-like ALL, compare the diagnostic and treatment differences between CML-like ALL and typical Ph+ ALL, and provide clinical evidence for standardized treatment of CML-like patients. Through a multicenter retrospective study, we hope to improve the diagnostic and treatment strategies for children with Ph+ ALL, enhancing patient survival rates and quality of life.
Official title: Real-world Investigation of Diagnosis, Treatment, and Survival Status of Children With Ph+ ALL in China
Key Details
Gender
All
Age Range
1 Month - 18 Years
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2025-08-01
Completion Date
2026-09
Last Updated
2026-09-10
Healthy Volunteers
No
Conditions
Locations (1)
The Children's Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China